Characterization of soy protein hydrolysates and influence of its iron content on monoclonal antibody production by a murine hybridoma cell line
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Biotechnology Progress, 37, (4), John Wiley & Sons
- Event
-
Veröffentlichung
- (where)
-
Darmstadt
- (who)
-
Universitäts- und Landesbibliothek
- (when)
-
2024
- DOI
-
10.26083/tuprints-00021528
- URN
-
urn:nbn:de:tuda-tuprints-215287
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Djemal, Leila
- Hagen, Jörg von
- Kolmar, Harald
- Deparis, Véronique
- Universitäts- und Landesbibliothek
Time of origin
- 2024
Other Objects (12)
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
X-ray structure of the murine monoclonal antibody MAK33
Monoclonal antibody therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
X-ray structure of the murine monoclonal antibody MAK33
Monoclonal antibody therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
X-ray structure of the murine monoclonal antibody MAK33
Monoclonal antibody therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System